purpose aim study determine risk factors late gastrointestinal gi morbidity hypofractionated carbon ion radiotherapy rt prostate cancer methods materials april NUMBER november NUMBER phase ii clinical trial rt total dose NUMBER gye NUMBER fractions performed NUMBER patients prostate cancer correlations clinical dosimetric parameters incidence late gi toxicity NUMBER patients survived NUMBER months investigated results grade late morbidities rectum observed grade NUMBER NUMBER morbidities developed NUMBER NUMBER NUMBER NUMBER patients respectively histogram analysis revealed percentage rectal volume receiving NUMBER prescribed dose v50 significantly higher patients rectal toxicity toxicity NUMBER NUMBER toxicity NUMBER NUMBER toxicity p NUMBER multivariate analysis demonstrated use anticoagulation therapy p NUMBER rectal v50 p NUMBER significant risk factors occurrence grade late gi toxicity conclusions rt hypofractionation yielded favorable results regarding late gi complication dosimetric parameter important factor occurrence rectal bleeding rt photon beam rt results provide useful information physicians applying charged particle rt treatment prostate cancer c ion c ion NUMBER NUMBER dose volume NUMBER NUMBER c ion c ion